0.2272
price down icon4.82%   -0.0115
pre-market  Pre-market:  .23   0.0028   +1.23%
loading
Hcw Biologics Inc stock is traded at $0.2272, with a volume of 196.46K. It is down -4.82% in the last 24 hours and down -36.31% over the past month.
See More
Previous Close:
$0.2387
Open:
$0.245
24h Volume:
196.46K
Relative Volume:
0.03
Market Cap:
$10.21M
Revenue:
$3.50M
Net Income/Loss:
$-37.33M
P/E Ratio:
-0.2272
EPS:
-1
Net Cash Flow:
$-19.15M
1W Performance:
-24.27%
1M Performance:
-36.31%
6M Performance:
-49.57%
1Y Performance:
-85.62%
1-Day Range:
Value
$0.2178
$0.245
1-Week Range:
Value
$0.2178
$0.296
52-Week Range:
Value
$0.2103
$2.52

Hcw Biologics Inc Stock (HCWB) Company Profile

Name
Name
Hcw Biologics Inc
Name
Phone
954-842-2024
Name
Address
2929 N COMMERCE PKWY, MIRAMAR
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-04-01
Name
Latest SEC Filings
Name
HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
HCWB
Hcw Biologics Inc
0.2272 10.21M 3.50M -37.33M -19.15M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Hcw Biologics Inc Stock (HCWB) Latest News

pulisher
Apr 03, 2025

HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener

Apr 02, 2025
pulisher
Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics Announces 1-for-40 Reverse Stock Split - citybiz

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics approves reverse stock split - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics approves 1-for-40 reverse stock split - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

HCW Biologics Announces 1-For-40 Reverse Stock Split - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail

Apr 01, 2025
pulisher
Mar 30, 2025

HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 30, 2025
pulisher
Mar 29, 2025

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - GlobeNewswire

Mar 29, 2025
pulisher
Mar 28, 2025

HCW Biologics Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan

Mar 28, 2025
pulisher
Mar 19, 2025

HCW Biologics amends agreement with WY Biotech amid delays - Investing.com

Mar 19, 2025
pulisher
Mar 11, 2025

Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail

Mar 11, 2025
pulisher
Mar 07, 2025

HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire

Mar 07, 2025
pulisher
Mar 06, 2025

HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan

Mar 06, 2025
pulisher
Feb 24, 2025

HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail

Feb 24, 2025
pulisher
Feb 10, 2025

HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater

Feb 10, 2025
pulisher
Feb 06, 2025

Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex

Feb 06, 2025
pulisher
Feb 05, 2025

The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 05, 2025
pulisher
Feb 04, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 04, 2025
pulisher
Feb 04, 2025

HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online

Feb 04, 2025
pulisher
Feb 04, 2025

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 04, 2025
pulisher
Feb 03, 2025

HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Feb 03, 2025
pulisher
Feb 03, 2025

Penny Stocks To ResearchFebruary 03rd - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

Pharma company granted FDA clearance for alopecia drug study - The Business Journals

Feb 03, 2025
pulisher
Feb 03, 2025

Crude Oil Moves Higher; Owens & Minor Shares Plummet - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

FDA approves HCW Biologics trial for alopecia treatment - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

What's Going On With HCW Biologics Stock Monday? - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

A Potential Breakthrough in the Fight Against Alopecia Areata: What You Need to Know About HCW Biologics Inc. - RagingBull

Feb 03, 2025
pulisher
Feb 03, 2025

Stock market news: MDJM surged by 74.54% while Tonix Pharmaceuticals Holding plunged by 49.31% during mid day trading - Business Upturn

Feb 03, 2025
pulisher
Feb 03, 2025

Dow Falls 150 Points; ISM Manufacturing PMI Rises In January - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Advances with FDA Clearance for Trial - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Stock market today: Tonix Pharmaceuticals Holding declined by 49.01% whereas HCW Biologics jumped by 176.78% in early trading - Business Upturn

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Granted FDA Clearance to Evaluate One of the - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

HCW Biologics Granted FDA Clearance to Evaluate One of the Company?s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - Marketscreener.com

Feb 03, 2025
pulisher
Jan 30, 2025

HCWB stock touches 52-week low at $0.25 amid market challenges - Investing.com Australia

Jan 30, 2025
pulisher
Jan 30, 2025

HCW Biologics (NASDAQ:HCWB) Shares Down 20% – Here’s Why - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

HCWB stock touches 52-week low at $0.25 amid market challenges By Investing.com - Investing.com South Africa

Jan 29, 2025

Hcw Biologics Inc Stock (HCWB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):